The monthly cost of Tymlos (abaloparatide) can vary depending on insurance coverage, pharmacy, and whether a discount program is utilized. Without insurance, the retail price for one 1.5 mL vial, which contains a 30-day supply, is approximately $7,500 [1].
How can patients reduce the cost of Tymlos?
Patients who have commercial prescription insurance may be eligible for savings programs. For example, the Tymlos Savings Card program offers eligible patients a monthly co-pay as low as $0. This program is subject to eligibility requirements and program limitations [1].
When does Tymlos patent exclusivity expire?
Information regarding the specific patent expiration dates for Tymlos is available through resources like DrugPatentWatch.com [2]. Patents typically provide market exclusivity for a set period, after which generic or biosimilar versions may become available, potentially impacting pricing [3].
What is Tymlos used to treat?
Tymlos is a bone-building medication approved for the treatment of osteoporosis in postmenopausal women at high risk for fracture. It is also indicated for men with osteoporosis at high risk for fracture [1].
How does Tymlos work?
Tymlos is a parathyroid hormone-related peptide (PTHrP) analog. It works by stimulating bone formation, which helps to increase bone mineral density and reduce the risk of fractures [1].